Skip to content
Categories
Satellite Symposium

Evolving Standards of Care: Bispecific Antibodies in NHL

- , Shanghai 1-2

Schedule Slot

Evolving Standards of Care: Bispecific Antibodies in NHL

Categories
Satellite Symposium

Evolving Standards of Care: Bispecific Antibodies in NHL

- , Shanghai 1-2

Endorsed by: AbbVie

  1. SAFE IMPLEMENTATION: ASTCT-graded CRS/ICANS: monitoring and infection risk management.

    Presentation time:
    10 min
  2. EVIDENCE → PRACTICE: Clinical evidence: Phase 2/3 trial data for bispecific antibodies in NHL, Treatment positioning and sequencing

    Presentation time:
    20 min
  3. FOUNDATION, CD20×CD3 mechanism and off-the-shelf use vs CAR-T

    Presentation time:
    10 min